In re Boston Scientific Corporation Securities Litigation

  1. December 15, 2023

    Boston Scientific Reaches $38.5M Deal To End Investor Suit

    Investors suing Boston Scientific Inc. for touting a heart valve product that was later pulled from the market announced Friday that they have settled their stock suit against the medical device maker for $38.5 million.

  2. October 23, 2023

    Boston Scientific Valve Recall Sparks Shareholder's Del. Suit

    Boston Scientific Corp.'s directors and top executives knew that a heart valve device that the company launched in 2019 was frequently causing complications and injuries, but nevertheless touted the product for months before pulling the device from the market, a new shareholder's Delaware Chancery Court complaint says.

  3. July 27, 2023

    Boston Scientific Says Stock Buys DQ Hopeful Lead Plaintiff

    Boston Scientific Corp. asked a Massachusetts federal judge Thursday to disqualify a German asset-management firm from serving as lead plaintiff in a proposed shareholder class action, arguing that the firm continued buying stock in Boston Scientific even after learning a highly touted heart device was pulled from the market.

  4. April 24, 2023

    Boston Scientific Investors Seek Class Cert. In Stock Suit

    Investors claiming Boston Scientific Inc. misled them about the prospects of a medical device asked a Massachusetts federal judge who had trimmed a previous version of their complaint to certify their class in a suit in which they claim thousands of investors were harmed when the device was ultimately recalled and the company's stock price fell.

  5. December 21, 2022

    Judge Trims Boston Scientific Investor's Stock Suit

    A Massachusetts federal judge trimmed a proposed class action Tuesday against medical device maker Boston Scientific and its executives, saying most of the misrepresentations alleged in the complaint are non-actionable and that the plaintiffs have not sufficiently alleged all the executives intentionally misled investors with their statements.

  6. January 04, 2022

    Boston Scientific Says Dead-End SEC Probe Sinks Stock Suit

    The U.S. Securities and Exchange Commission is not bringing securities claims against Boston Scientific for halting the production of its Lotus Edge heart device, the company said Monday as it sought to undercut a related suit brought by investors in New York and Massachusetts.

  7. November 19, 2021

    Boston Scientific Investors Told To Get To Heart Of Stock Suit

    Investors claiming Boston Scientific Inc. misled them about the prospects of a medical device were told by a Boston federal judge on Friday to present him the "jugular" of their case and not waste precious time on rhetorical and argumentative "capillaries."